0      0

120 - Biosimilar Medications: What Nephrology APNs and Nurses Need to Know

‐ Oct 12, 2014 1:30pm

Contact hours available until 10/13/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.

Faculty, Planners, and Speakers Conflict of Interest Disclosure:

Planning Commitee disclosures:
• Denise Murcek - Per diem employee, Fresenius Medical Care
• Melissa Nesmith-Vester – Employee, Aegerion
• Elizabeth St. John - Employee, Fresenius Medical Care
• Kyra Trappett – Employee, DaVita

Faculty and speakers have no disclosures to declare.

Commercial Support and Sponsorship:
Supported by an educational grant from Amgen

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

  • Discuss the origins of biopharmaceutical and biosimilar medications.
  • Examine the technology that has led to the development of biosimilars in immunologic therapies and in anemia management.
  • Review the important differences between generic medications and biosimilar agents.
  • Discuss strategies that can be implemented to successfully improve patient safety when utilizing biosimilar agents.


You must be logged in and own this session in order to post comments.